PMID: 11918864Mar 29, 2002Paper

The cost of treating allergic rhinitis

Current Allergy and Asthma Reports
David A Stempel, Roger Woolf

Abstract

Allergic rhinitis is a high-cost, high-prevalence disease. In the year 2000, over $6 billion was spent on prescription medications to treat this illness. Although it is not associated with severe morbidity and mortality, allergic rhinitis has a major effect on the quality of life of the more than 50 million Americans with this illness. Intranasal corticosteroids (INCS) and nonsedating antihistamines (NSAH) are the most common prescription medications for this disease. INCS are recognized as the most effective treatment regimen for chronic symptoms. NSAH are perceived as important in the treatment of patients with mild disease, or as add-on therapy to INCS. When the literature is reviewed, the INCS produce the greatest decrease in total nasal symptom scores, the largest effect size, when compared with NSAH. Both classes of medications produce similar effects on concurrent allergic conjunctivitis. Further recent studies indicate that the INCS are also superior when used on an as-needed basis, and that there is little clinical benefit from the addition of loratadine to intranasal fluticasone. INCS have lower average wholesale prices as a class than the NSAH. Since the INCS are the dominant medication in efficacy studies and cost l...Continue Reading

References

Dec 1, 1992·The Journal of Allergy and Clinical Immunology·S L Spector
Nov 1, 1996·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·F E Simons
Jan 1, 1997·The Journal of Allergy and Clinical Immunology·D C MaloneC Battista
Jun 1, 1997·The Journal of Allergy and Clinical Immunology·E O Meltzer
Aug 20, 1997·JAMA : the Journal of the American Medical Association·C Marwick
Apr 8, 1998·Otolaryngologic Clinics of North America·B J Ferguson
Dec 22, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·M S Dykewicz, S Fineman
Jun 3, 1999·American Journal of Respiratory and Critical Care Medicine·T PulleritsJ Lötvall
Jun 3, 1999·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·T B CasaleJ Oren
Oct 16, 1999·The Journal of Allergy and Clinical Immunology·J Corren
Apr 5, 2000·Allergy and Asthma Proceedings·M S Blaiss
Apr 11, 2000·The Journal of Allergy and Clinical Immunology·A JenR Naclerio
May 16, 2000·The Journal of Allergy and Clinical Immunology·L Derby, W C Maier
Jun 10, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P Van Cauwenberge, E F Juniper
Aug 10, 2000·The Journal of Allergy and Clinical Immunology·E AdelrothT Sandström

❮ Previous
Next ❯

Citations

Mar 29, 2003·Current Allergy and Asthma Reports·Samantha M Mucha, Fuad M Baroody
Apr 29, 2010·Current Allergy and Asthma Reports·Timothy J CraigSahar Safaee
Sep 15, 2004·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Michael StokesGeorge Georges
Jul 27, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Paul ChervinskyTushar Shah
Oct 5, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Bernd LangeClaus Bachert
Sep 28, 2002·Current Opinion in Pediatrics·Kelly D Stone
Jun 26, 2014·Pediatric Allergy, Immunology, and Pulmonology·Cynthia A EstebanDaphne Koinis-Mitchell
Mar 18, 2004·Current Medical Research and Opinion·William F SchoenwetterChris L Pashos
Oct 4, 2011·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Thomas B CasaleAnish Bhatnagar
May 31, 2011·Otolaryngologic Clinics of North America·Christine Franzese
Feb 15, 2011·Sleep Medicine Reviews·Michael Lunn, Timothy Craig
Feb 10, 2011·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Eli O Meltzer, Don A Bukstein
Aug 26, 2010·The Medical Clinics of North America·Christine B Franzese, Neal W Burkhalter
Oct 12, 2010·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Joseph P Forester, Christopher W Calabria
Apr 29, 2008·American Journal of Otolaryngology·Timothy J CraigJohn H Krouse
Nov 22, 2007·The Journal of Allergy and Clinical Immunology·Thomas B CasaleEgilius L H Spierings
Sep 14, 2011·The Mount Sinai Journal of Medicine, New York·Tania MucciJody Tversky
Jan 12, 2013·International Forum of Allergy & Rhinology·Sandra Y LinStacey L Ishman
Jan 22, 2014·Journal of Evaluation in Clinical Practice·George Dranitsaris, Anne K Ellis
Feb 5, 2014·International Forum of Allergy & Rhinology·Kevin HurSandra Y Lin
Sep 3, 2004·Journal of Photochemistry and Photobiology. B, Biology·Zsanett CsomaLajos Kemeny
Apr 5, 2005·The Journal of Allergy and Clinical Immunology·Rachel EnriquezVictoria Persky
Nov 26, 2013·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Alison ThompsonTimothy J Craig
Aug 11, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Joel W Hay, Michael Leahy
May 24, 2017·Postgraduate Medicine·Warner W Carr, Barbara P Yawn
Feb 21, 2018·International Forum of Allergy & Rhinology·Shelley R BersonManoj Abraham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved